SCHEMBL4038877

SCHEMBL4038877

COC(=O)c1cnc(N(OC(C)(C)C)C(=O)OC(C)(C)C)s1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
USP30 Q70CQ3 1/20 0.37
TMPRSS15 P98073 9/20 0.36
ATR Q13535 1/20 0.36
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
FFAR2 O15552 1/20 0.33
CSNK2A2 P19784 1/20 0.32
KDR P35968 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
NPC1 O15118 1/20 0.32
PKM P14618 1/20 0.32
CRBN Q96SW2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4038874 0.85 ALDH1A1 (0.44) ALDH1A1USP30TMPRSS15ATRHPGD
SCHEMBL31464198 0.74 ALDH1A1 (0.41) ALDH1A1USP30TMPRSS15ATRHPGD
SCHEMBL3141257 0.73 MAPT (0.34) ALDH1A1TSHR
SCHEMBL6496980 0.72 HCAR2 (0.44) ALDH1A1USP30TMPRSS15HPGDTSHR
SCHEMBL23451253 0.71 USP30 (0.39) ALDH1A1USP30FFAR2NPC1PKM
SCHEMBL12496166 0.71 CDC7 (0.47) ALDH1A1USP30TMPRSS15HPGDL3MBTL1
SCHEMBL6496922 0.70 CDC7 (0.46) ALDH1A1USP30TMPRSS15HPGD
SCHEMBL1131936 0.70 FFAR2 (0.48) ALDH1A1ATRHPGDFFAR2
SCHEMBL28474114 0.69 ALDH1A1 (0.41) ALDH1A1USP30TMPRSS15TSHRFFAR2
SCHEMBL20924287 0.68 TMPRSS15 (0.47) TMPRSS15HPGDTSHRMAPK1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268443-B1 2-HYDROXY-MUTILIN CARBAMATE DERIVATIVES FOR ANTIBACTERIAL USE SMITHKLINE BEECHAM PLC (GB) 2009-07-29 EP disclosed
US-6972297-B2 2-Hydroxy-mutilin carbamate derivatives for antibacterial use SMITHKLINE BEECHAM P.L.C. (GB) 2005-12-06 US disclosed
US-20030114674-A1 2-Hydroxy-mutilin carbamate derivatives for antibacterial use SMITHKLINE BEECHAM P.L.C. (GB) 2003-06-19 US disclosed
EP-1268443-A1 2-HYDROXY-MUTILIN CARBAMATE DERIVATIVES FOR ANTIBACTERIAL USE SmithKline Beecham p.l.c. (GB) 2003-01-02 EP disclosed
WO-2001074788-A1 2-HYDROXY-MUTILIN CARBAMATE DERIVATIVES FOR ANTIBACTERIAL USE SMITHKLINE BEECHAM PLC (GB) 2001-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030114674-A1 2-Hydroxy-mutilin carbamate derivatives for antibacterial use MSH6, MSH2, PMS2 ALDH1A1 1967/4885USP30 341/4885TMPRSS15 1327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.